Greenwood Capital Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.65M Sell
37,981
-9,189
-19% -$2.14M 0.95% 24
2026
Q1
$11.5M Sell
47,170
-1,639
-3% -$382K 1.27% 15
2025
Q4
$10.1M Sell
48,809
-1,915
-4% -$379K 1.1% 18
2025
Q3
$9.41M Sell
50,724
-1,097
-2% -$188K 1.09% 21
2025
Q2
$7.92M Sell
51,821
-2,162
-4% -$332K 0.98% 25
2025
Q1
$8.95M Sell
53,983
-15,096
-22% -$2.36M 1.21% 20
2024
Q4
$9.99M Sell
69,079
-2,848
-4% -$441K 1.3% 16
2024
Q3
$11.7M Buy
71,927
+5,858
+9% +$933K 1.52% 13
2024
Q2
$9.66M Sell
66,069
-674
-1% -$100K 1.27% 17
2024
Q1
$10.6M Sell
66,743
-19,071
-22% -$3.04M 1.4% 13
2023
Q4
$13.5M Sell
85,814
-270
-0.3% -$41.4K 1.74% 6
2023
Q3
$13.4M Sell
86,084
-3,957
-4% -$653K 1.95% 5
2023
Q2
$14.9M Buy
90,041
+2,096
+2% +$338K 2.09% 5
2023
Q1
$13.6M Buy
87,945
+917
+1% +$148K 1.96% 6
2022
Q4
$15.4M Sell
87,028
-4,004
-4% -$691K 2.52% 3
2022
Q3
$14.9M Sell
91,032
-10,861
-11% -$1.84M 2.55% 4
2022
Q2
$18.1M Buy
101,893
+101,074
+12,341% +$18M 2.9% 3
2022
Q1
$145K Sell
819
-80,185
-99% -$13.6M 0.04% 141
2021
Q4
$13.9M Buy
81,004
+1,482
+2% +$243K 1.96% 8
2021
Q3
$12.8M Buy
79,522
+334
+0.4% +$57K 1.97% 9
2021
Q2
$13M Sell
79,188
-1,668
-2% -$276K 1.97% 10
2021
Q1
$13.3M Sell
80,856
-5,825
-7% -$943K 2.09% 10
2020
Q4
$13.6M Buy
86,681
+4,268
+5% +$630K 2.29% 8
2020
Q3
$12.3M Buy
82,413
+5,167
+7% +$765K 2.38% 6
2020
Q2
$10.9M Sell
77,246
-11,271
-13% -$1.64M 2.48% 7
2020
Q1
$11.6M Sell
88,517
-745
-0.8% -$106K 3.41% 2
2019
Q4
$13M Buy
89,262
+4,051
+5% +$549K 2.75% 4
2019
Q3
$11M Buy
85,211
+6,169
+8% +$813K 2.68% 4
2019
Q2
$11M Buy
79,042
+937
+1% +$130K 2.77% 3
2019
Q1
$10.9M Buy
78,105
+496
+0.6% +$66.4K 2.81% 6
2018
Q4
$10M Buy
77,609
+14,841
+24% +$2.07M 2.63% 5
2018
Q3
$8.67M Sell
62,768
-240
-0.4% -$31.9K 1.89% 11
2018
Q2
$7.64M Buy
63,008
+2,900
+5% +$362K 1.76% 13
2018
Q1
$7.7M Buy
60,108
+4,820
+9% +$651K 1.88% 7
2017
Q4
$7.72M Sell
55,288
-629
-1% -$87.6K 1.8% 9
2017
Q3
$7.27M Sell
55,917
-1,249
-2% -$166K 1.81% 9
2017
Q2
$7.56M Sell
57,166
-223
-0.4% -$28.4K 1.97% 8
2017
Q1
$7.15M Sell
57,389
-11,332
-16% -$1.35M 1.87% 7
2016
Q4
$7.92M Buy
68,721
+4,695
+7% +$542K 2.24% 6
2016
Q3
$7.56M Sell
64,026
-1,161
-2% -$141K 2.29% 5
2016
Q2
$7.91M Sell
65,187
-1,013
-2% -$115K 2.43% 5
2016
Q1
$7.16M Sell
66,200
-4,086
-6% -$423K 2.26% 5
2015
Q4
$7.22M Sell
70,286
-746
-1% -$75K 2.33% 5
2015
Q3
$6.63M Sell
71,032
-1,779
-2% -$172K 2.35% 4
2015
Q2
$7.1M Sell
72,811
-2,406
-3% -$241K 2.15% 5
2015
Q1
$7.57M Sell
75,217
-1,400
-2% -$142K 2.17% 5
2014
Q4
$8.01M Buy
76,617
+2,041
+3% +$215K 2.32% 4
2014
Q3
$7.95M Buy
74,576
+523
+0.7% +$54.2K 2.44% 4
2014
Q2
$7.75M Sell
74,053
-640
-0.9% -$64.7K 2.4% 4
2014
Q1
$7.34M Sell
74,693
-5,383
-7% -$499K 2.36% 4
2013
Q4
$7.33M Sell
80,076
-329
-0.4% -$30.3K 2.28% 4
2013
Q3
$6.97M Sell
80,405
-398
-0.5% -$35.7K 2.46% 4
2013
Q2
$6.94M Buy
+80,803
New +$6.86M 3.01% 4

Other funds holding JNJ

Greenwood Capital Associates's JNJ Position: Q2 2026 in Review

Greenwood Capital Associates reduced its Johnson & Johnson (JNJ) stake by 19% in Q2 2026, selling an estimated $2.14M and leaving 37,981 shares worth $9.65M. The position accounts for 0.95% of the portfolio, ranked #24.

Greenwood Capital Associates first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.1M in Q2 2022. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Greenwood Capital Associates held 37,981 shares of Johnson & Johnson worth $9.65M as of Q2 2026.
  • Greenwood Capital Associates sold 9,189 Johnson & Johnson shares in Q2 2026, an estimated $2.14M.
  • Johnson & Johnson made up 0.95% of Greenwood Capital Associates's portfolio in Q2 2026, its #24 holding.
  • Greenwood Capital Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Greenwood Capital Associates's Johnson & Johnson position peaked at $18.1M in Q2 2022.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.